What can cause a false positive for methamphetamines on a urine drug screen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of False Positive Methamphetamine Results on Urine Drug Screens

Over-the-counter cold medications containing pseudoephedrine are the most common cause of false positive methamphetamine results on urine drug screens. 1

Common Medications That Can Cause False Positive Methamphetamine Results

Prescription Medications:

  • Bupropion (Wellbutrin): The most frequent cause of false positive amphetamine/methamphetamine screens in clinical settings 2

    • In one study, 41% of false positive amphetamine screens were associated with bupropion use 2
    • The FDA label specifically warns that bupropion can cause false-positive urine test results for amphetamines 3
  • Metoprolol: Can cross-react with both amphetamine and MDMA immunoassays at relatively low concentrations 4

    • Metoprolol itself shows positive results at 200 μg/mL for amphetamine and 150 μg/mL for MDMA tests
    • Its metabolites (α-hydroxymetoprolol and O-demethylmetoprolol) can also cross-react at higher concentrations
  • Trazodone: Its metabolite meta-chlorophenylpiperazine (m-CPP) can cause false-positive amphetamine results 5

    • Strong correlation between m-CPP concentration and amphetamine immunoreactivity
    • Can produce sufficient m-CPP to trigger false positives in routine clinical testing
  • Other medications that can cause false positive amphetamine/methamphetamine results include:

    • Antidepressants: sertraline, venlafaxine, clomipramine 6
    • Antipsychotics: quetiapine, chlorpromazine, thioridazine, promethazine 6
    • Other: ranitidine, verapamil 6

Over-the-Counter Medications:

  • Pseudoephedrine (found in many cold and allergy medications) 1
  • Dextromethorphan (cough suppressant) 6
  • Nasal inhalers (some non-prescription types) 6
  • Antihistamines: brompheniramine, diphenhydramine, doxylamine 6

Other Substances:

  • Benzphetamine (Didrex): Metabolized to methamphetamine and amphetamine 7
    • Can produce positive urine tests in some individuals
    • The ratio of amphetamine to methamphetamine differs from direct methamphetamine use

Testing Considerations and Interpretation

Understanding Test Limitations:

  1. Immunoassay limitations:

    • Screening tests are based on immunoassays which lack specificity due to cross-reactivity
    • False positives are common with amphetamine/methamphetamine screens
  2. Confirmation testing:

    • All positive screening results should be confirmed with gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-mass spectrometry (LC-MS/MS) 1, 8
    • These confirmatory methods are highly specific and can reliably identify the actual substance present
  3. Detection windows:

    • Amphetamines typically have a detection window of 1-3 days after use 8

Clinical Approach to Interpreting Positive Results

  1. Medication review: Always document all medications the patient is currently taking, including OTC medications and supplements 8

  2. Confirmatory testing: Order GC-MS or LC-MS/MS confirmation for any positive screening result 1, 8

  3. Patient discussion: Discuss unexpected positive results with the patient in a non-judgmental manner before making conclusions 8

  4. Consider common cross-reactants: Be particularly aware of bupropion, pseudoephedrine, and other medications listed above when interpreting positive amphetamine/methamphetamine screens

Key Pitfalls to Avoid

  1. Making decisions based on screening results alone: Never make clinical decisions based solely on immunoassay results without confirmation

  2. Ignoring medication history: Failing to consider the patient's complete medication profile when interpreting results

  3. Overlooking the possibility of false positives: Particularly with amphetamine/methamphetamine screens, which have numerous documented cross-reactants

  4. Dismissing patients based on unconfirmed positive results: This could constitute patient abandonment and lead to worse outcomes 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Frequency of false positive amphetamine screens due to bupropion using the Syva EMIT II immunoassay.

Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2011

Research

Commonly prescribed medications and potential false-positive urine drug screens.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010

Guideline

Fentanyl Detection and Management in Clinical Settings

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.